Advancing
MEF2C
Therapeutics
We are on a mission to find the first-ever drug to tackle MEF2C deficiency.
Join us.
rare bird (noun):
an exceptional person or thing; a rarity
$1.1m Grant from Rare Bird Funds First Longitudinal Natural History Study for MCHS
The Volare Study marks a historic global commitment
from the MEF2C community to chart the course of
MCHS and prepare for clinical trial.
Rare Bird Foundation X Weill Cornell Medical Center (NY) X
Weill Cornell Medical Center (Doha) X Sidra Hospital (Doha) X
MEF2C Foundation (UK) X MEF2C Foundation (Australia) X
MEF2C Hilfsorganisation (Germany)
JOIN THE MOVEMENT. CHANGE HISTORY.
The Rare Bird Foundation is a U.S.-based organization dedicated to advancing and promulgating research that improves the understanding and development of therapeutics for MEF2C Haploinsufficiency Syndrome (MCHS), a rare neurodevelopmental disease that affects 350 children and young adults worldwide.
Fluff Your Feathers
Show your MEF2C pride with merch
that looks great and supports our work.
Funding the future
Our team is the largest single funder of MEF2C-focused research and therapeutic development. Email us to join the effort.